Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Napoli

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 25, 2026
Cardiometabolic Risk in Bilateral vs Unilateral Nonfunctioning Adrenal Incidentalomas: Evidence From a Large Referral Center CohortElisa Febbraro, Matteo Procopio, Sara Napoli, et al.
American Journal of Cancer Research|June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma modelsFilippo Spriano, Luca Aresu, Luciano Cascione, et al.
Cancer Research|September 26, 2013
RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancerGianluca Civenni, Anastasia Malek, Domenico Albino, et al.
Haematologica|December 23, 2003
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infectionMassimo Di Nicola, Sara Napoli, Andrea Anichini, et al.
Nucleic Acids Research|March 31, 2006
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapyVeronica Albertini, Aklank Jain, Sara Vignati, et al.
Children (Basel, Switzerland)|June 28, 2023
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on PediatricsClaudia Mandato, Angelo Colucci, Roberta Lanzillo, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like typeChiara Tarantelli, Eleonora Cannas, Hillarie Ekeh, et al.
Ejhaem|September 2, 2022
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphomaFilippo Spriano, Giulio Sartori, Chiara Tarantelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 12, 2021
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphomaGiulio Sartori, Sara Napoli, Luciano Cascione, et al.
Cancers|July 19, 2020
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like TypeValdemar Priebe, Giulio Sartori, Sara Napoli, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 25, 2026
Cardiometabolic Risk in Bilateral vs Unilateral Nonfunctioning Adrenal Incidentalomas: Evidence From a Large Referral Center CohortElisa Febbraro, Matteo Procopio, Sara Napoli, et al.
American Journal of Cancer Research|June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma modelsFilippo Spriano, Luca Aresu, Luciano Cascione, et al.
Cancer Research|September 26, 2013
RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancerGianluca Civenni, Anastasia Malek, Domenico Albino, et al.
Haematologica|December 23, 2003
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infectionMassimo Di Nicola, Sara Napoli, Andrea Anichini, et al.
Nucleic Acids Research|March 31, 2006
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapyVeronica Albertini, Aklank Jain, Sara Vignati, et al.
Children (Basel, Switzerland)|June 28, 2023
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on PediatricsClaudia Mandato, Angelo Colucci, Roberta Lanzillo, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like typeChiara Tarantelli, Eleonora Cannas, Hillarie Ekeh, et al.
Ejhaem|September 2, 2022
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphomaFilippo Spriano, Giulio Sartori, Chiara Tarantelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 12, 2021
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphomaGiulio Sartori, Sara Napoli, Luciano Cascione, et al.
Cancers|July 19, 2020
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like TypeValdemar Priebe, Giulio Sartori, Sara Napoli, et al.
Pageof 5